Trial Details

COMPLETED
Basic Information
Clinical ID c933
Identifier NCT04963725
Trial Title A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Ustekinumab
Participant Information
Sponsor Janssen Pharmaceutical K.K.
City Bunkyo Ku
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2021-07-18
Primary Completion Date 2022-12-01
Completion Date 2022-12-01